AstraZeneca signs agreement with Chinese firm for oral obesity drug
Anglo-Swedish drug company AstraZeneca announced that it signed a licensing agreement with Eccogene, a Chinese firm for oral medicines which will treat diabetes and obesity on Thursday, 9 November 2023. …
AstraZeneca signs agreement with Chinese firm for oral obesity drug Read More